SHL Telemedicine (SHLT) 6-K SHL Telemedicine strengthens leadership of its German operation

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of: April 2023

001-41641 

(Commission File Number)

SHL TELEMEDICINE LTD. 

(Translation of registrant’s name into English)

90 Yigal Alon Street 

Tel Aviv 67891, Israel 

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F x Form 40-F ¨

INFORMATION CONTAINED IN THIS FORM 6-K REPORT

On April 4, 2023, SHL Telemedicine Ltd. (the "Company") issued a press release announcing that Mr. Bernd Altpeter was nominated as Co-Managing Director of the SHL German Operation. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The press release contains forward-looking statements and includes cautionary statements identifying important factors that could cause actual results to differ materially from those in the forward-looking statements.

Exhibit	Description
99.1	Press Release dated April 4, 2023

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

SHL TELEMEDICINE LTD.
By:	/s/ Erez Nachtomy
	Name:	Erez Nachtomy
	Title:	Chief Executive Officer

Date: April 4, 2023